OnTrackCF: Engagement, Feasibility, and Acceptability Study
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorBoston Children's Hospital
About this trial
This is a multi-site, nonrandomized study using mixed methods approach to evaluate the feasibility, acceptability, and user engagement of OnTrackCF for adults with Cystic Fibrosis (AWCF).
Eligibility criteria
Qualifiers
Diagnosed with CF
18+ years of age
Prescribed a CFTR modulator therapy to be taken twice a day
Can speak and read English
Disqualifiers
None
Trial design
Treatments tested in this trial
- OnTrackCF
Treatment groups
60 Participants
are divided into 1 treatment groupSponsors and collaborators
Boston Children's Hospital
Lead sponsor
Cystic Fibrosis Foundation
Collaborator
Johns Hopkins University
Collaborator
University of Alabama at Birmingham
Collaborator
Source ClinicalTrials.gov